Pee test could replace scopes for bladder cancer monitoring

NCT ID NCT05982561

Recruiting now Diagnosis Sponsor: Early is Good Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing BCDx, a urine-based test designed to detect the return of non-muscle invasive bladder cancer (NMIBC) earlier and without a scope. Researchers will enroll 500 people with a history of NMIBC and compare the test's accuracy to standard cystoscopy. If it works, it could offer a simpler, less invasive way to monitor for recurrence.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: BCDx urine test
What this could lead to: If successful, BCDx could offer a simple, noninvasive urine test to catch bladder cancer recurrence early, reducing the need for frequent cystoscopies.
What could go wrong: This is a diagnostic accuracy study, not a treatment trial. The test may not be sensitive or specific enough to replace standard monitoring, and results may not apply to all bladder cancer patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-invasive bladder urothelial carcinoma urinary bladder carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLADDER CANCER

Contacts and locations

Locations

Arkansas Urology Research Center
RECRUITING

Little Rock, Arkansas, 72211, United States
Indiana University School of Medicine
RECRUITING

Indianapolis, Indiana, 46202, United States
Washington University
RECRUITING

St Louis, Missouri, 63130, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.